OBJECTIVE: To assess the clinimetric properties of a new health-related quality of life (HRQOL) instrument, the World Health Organization Disability Assessment Schedule II (WHODAS II), in patients with early inflammatory arthritis. METHODS: Internal consistency as well as criterion, construct, and discriminative validity of the WHODAS II were assessed in 172 patients with early inflammatory arthritis who completed the WHODAS II, the Medical Outcomes Study Short Form 36 (SF-36), and other measures of disease severity, functioning, pain, depression, and resource use. Test-retest reliability of the WHODAS II was assessed by having a subset of 20 patients complete the WHODAS II a second time, 1 week after the first assessment. RESULTS: The WHODAS II had high internal consistency (Cronbach's alpha = 0.96 for patients working or in school and 0.93 for patients not working or in school). Test-retest intraclass correlation coefficients of the WHODAS II total score and subscales ranged from 0.82-0.96. The WHODAS II total score was strongly correlated with the SF-36 physical component score (Kendall's tau-b 0.51, P < 0.001) and moderately correlated with the SF-36 mental component score (tau-b 0.43, P < 0.001). WHODAS II correlations with disease outcomes ranged from Kendall's tau-b 0.15-0.55. The WHODAS II significantly differentiated between every aspect of disease severity assessed with the exception of measures of health resource use. CONCLUSION: The WHODAS II is a valid and reliable measure of HRQOL in cross-sectional studies of patients with early inflammatory arthritis. Research is still required to investigate potential item redundancy and determine its usefulness in longitudinal studies.
OBJECTIVE: To assess the clinimetric properties of a new health-related quality of life (HRQOL) instrument, the World Health Organization Disability Assessment Schedule II (WHODAS II), in patients with early inflammatory arthritis. METHODS: Internal consistency as well as criterion, construct, and discriminative validity of the WHODAS II were assessed in 172 patients with early inflammatory arthritis who completed the WHODAS II, the Medical Outcomes Study Short Form 36 (SF-36), and other measures of disease severity, functioning, pain, depression, and resource use. Test-retest reliability of the WHODAS II was assessed by having a subset of 20 patients complete the WHODAS II a second time, 1 week after the first assessment. RESULTS: The WHODAS II had high internal consistency (Cronbach's alpha = 0.96 for patients working or in school and 0.93 for patients not working or in school). Test-retest intraclass correlation coefficients of the WHODAS II total score and subscales ranged from 0.82-0.96. The WHODAS II total score was strongly correlated with the SF-36 physical component score (Kendall's tau-b 0.51, P < 0.001) and moderately correlated with the SF-36 mental component score (tau-b 0.43, P < 0.001). WHODAS II correlations with disease outcomes ranged from Kendall's tau-b 0.15-0.55. The WHODAS II significantly differentiated between every aspect of disease severity assessed with the exception of measures of health resource use. CONCLUSION: The WHODAS II is a valid and reliable measure of HRQOL in cross-sectional studies of patients with early inflammatory arthritis. Research is still required to investigate potential item redundancy and determine its usefulness in longitudinal studies.
Authors: T Bedirhan Ustün; Somnath Chatterji; Nenad Kostanjsek; Jürgen Rehm; Cille Kennedy; Joanne Epping-Jordan; Shekhar Saxena; Michael von Korff; Charles Pull Journal: Bull World Health Organ Date: 2010-05-20 Impact factor: 9.408
Authors: Noelle E Carlozzi; Anna L Kratz; Nancy R Downing; Siera Goodnight; Jennifer A Miner; Nicholas Migliore; Jane S Paulsen Journal: Qual Life Res Date: 2015-01-31 Impact factor: 4.147
Authors: Juan V Luciano; José L Ayuso-Mateos; Ana Fernandez; Jaume Aguado; Antoni Serrano-Blanco; Miquel Roca; Josep M Haro Journal: Qual Life Res Date: 2009-12-18 Impact factor: 4.147
Authors: Juan V Luciano; José L Ayuso-Mateos; Jaume Aguado; Ana Fernandez; Antoni Serrano-Blanco; Miquel Roca; Josep M Haro Journal: BMC Med Res Methodol Date: 2010-05-20 Impact factor: 4.615
Authors: Olatz Garin; Jose Luis Ayuso-Mateos; Josué Almansa; Marta Nieto; Somnath Chatterji; Gemma Vilagut; Jordi Alonso; Alarcos Cieza; Olga Svetskova; Helena Burger; Vittorio Racca; Carlo Francescutti; Eduard Vieta; Nenad Kostanjsek; Alberto Raggi; Matilde Leonardi; Montse Ferrer Journal: Health Qual Life Outcomes Date: 2010-05-19 Impact factor: 3.186
Authors: Renata M Sousa; Cleusa P Ferri; Daisy Acosta; Emiliano Albanese; Mariella Guerra; Yueqin Huang; K S Jacob; A T Jotheeswaran; Juan J Llibre Rodriguez; Guillermina Rodriguez Pichardo; Marina Calvo Rodriguez; Aquiles Salas; Ana Luisa Sosa; Joseph Williams; Tirso Zuniga; Martin Prince Journal: Lancet Date: 2009-11-28 Impact factor: 79.321
Authors: Renata M Sousa; Michael E Dewey; Daisy Acosta; A T Jotheeswaran; Erico Castro-Costa; Cleusa P Ferri; Mariella Guerra; Yueqin Huang; K S Jacob; Juana Guillermina Rodriguez Pichardo; Nayeli Garcia Ramírez; Juan Llibre Rodriguez; Marina Calvo Rodriguez; Aquiles Salas; Ana Luisa Sosa; Joseph Williams; Martin J Prince Journal: Int J Methods Psychiatr Res Date: 2010-03 Impact factor: 4.035
Authors: Aimie L Peek; Andrew M Leaver; Sheryl Foster; Georg Oeltzschner; Nicolaas A Puts; Graham Galloway; Michele Sterling; Karl Ng; Kathryn Refshauge; Maria-Eliza R Aguila; Trudy Rebbeck Journal: J Pain Date: 2021-06-25 Impact factor: 5.820